2021 Southeastern Section of the American Urological Association

Viewing 1-16 of 16 articles

SES AUA 2021: Prostate Biopsy in 2021 - What is Current Best Practice?

SES AUA 2021: Prostate Cancer: Genetics and Markers

SES AUA 2021: Modern Bladder Cancer Warfare: Does "Leave No Bladder Behind" Ethos Still Apply?

SES AUA 2021: Contemporary Management of Advanced Prostate Cancer - Decisions Based on Precision and Better Ammunition

SES AUA 2021: Ambrose Reed Lecture: May I Have This Dance? The Importance of Diversity and Inclusion in Urology

SES AUA 2021: Financial Toxicity in Urologic Oncology

SES AUA 2021: Quality Metrics for the Urologist

SES AUA 2021: Imaging in Prostate Cancer: Shiny New Things

SES AUA 2021: A Comparison of the Aortic-Lesion-Attenuation-Difference (ALAD) and Peak Early-Phase Enhancement Ratio (PEER) to Preoperatively Differentiate Benign from Malignant Renal Masses

SES AUA 2021: Results from Targeted Germline Sequencing in Men on Active Surveillance for Prostate Cancer

SES AUA 2021: Does MRI Demonstrate Racial Differences in Prostate Cancer Lesions by Zone?

SES AUA 2021: Genetic Testing in Prostate Cancer - Understanding the Implications for Early Detection, Localized Disease & Castration-Resistant Prostate Cancer

SES AUA 2021: miRNA-301A: A Potential Health Disparity Marker in Men with Prostate Cancer

SES AUA 2021: Objective Risk Score Reliably Predicts Mortality After Radical Nephrectomy

SES AUA 2021: The Critical Pursuit of Social Justice in Urology

SES AUA 2021: Avelumab First-Line Maintenance + Best Supportive Care (BSC) vs BSC Alone with 1L Chemotherapy for Advanced Urothelial Carcinoma: JAVELIN Bladder 100 Subgroup Analyses

email news signup